(Q30403035)

21 June 2017

title

The changing landscape of progressive multifocal leukoencephalopathy (English)

1 reference

progressive multifocal leukoencephalopathy

21 June 2017

main subject

0 references

Sachin Kedar

1

0 references

author name string

Joseph R Berger

series ordinal

2

1 reference

21 June 2017

publication date

1 August 2011

1 reference

Current infectious disease reports

21 June 2017

published in

1 reference

21 June 2017

volume

13

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

380-386

1 reference

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leucoencephalopathy: Analysis of JC virus DNA from brain and kidney tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

JC virus detection in bodily fluids: clues to transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Prevalence Rate and Age of Acquisition of Antibodies against JC Virus and BK Virus in Human Sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Characterization of JC human polyomavirus infection in a Portuguese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Anti-JC virus antibodies: implications for PML risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy: clinical and radiographic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive Multifocal Leukoencephalopathy in Acquired Immunodeficiency Syndrome: Explaining the High Incidence and Disproportionate Frequency of the Illness Relative to Other Immunosuppressive Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Akinetic-rigid syndrome in a 13-year-old girl with HIV-related progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Low prevalence of Progressive Multifocal Leukoencephalopathy in India and Africa: Is There a Biological Explanation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Incidence of progressive multifocal leukoencephalopathy in patients without HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Monoclonal antibodies and progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Reemergence of PML in natalizumab-treated patients--new cases, same concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy and newer biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

The human polyomavirus, JCV, uses serotonin receptors to infect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0196-6

Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection

21 January 2018

1 reference

12 December 2020

Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in HIV-1-infected children

1 reference

12 December 2020

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

1 reference

12 December 2020

Cellular and humoral immune response in progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Neurovirulence and host factors in flavivirus encephalitis--evidence from clinical epidemiology

1 reference

12 December 2020

Progressive Multifocal Leukoencephalopathy in a Male Homosexual with T-Cell Immune Deficiency

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in an HIV-infected child

1 reference

12 December 2020

10.1007/S11908-011-0196-6

Identifiers

DOI

1 reference

21 June 2017

1 reference